This week's stock market saw the S&P 500 rise 3.4%, fueled by positive inflation data and strong earnings reports.

GLP-1 drugs have become all the rage for weight loss, with sales for drugs like Novo Nordisk's Ozempic and Eli Lilly's (NYSE: ...

Equities researchers at Leerink Partnrs decreased their FY2024 earnings per share estimates for shares of Eli Lilly and ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Intuitive Surgical (ISRG – Research Report) on January 15 and set a price ...

Adj. EPS At Lower End Of $1.75-$2.05 Due To Flash Pricing Challenges Vs $1.88 Est. National Vision Q4 Preliminary Net Revenue From Continuing Operations Of $437M (Est $433.55M), Comparable Store ...